单核苷酸多形性微阵列在bap1失活黑色素细胞肿瘤分类中的作用。

IF 3.9 2区 医学 Q2 CELL BIOLOGY
Histopathology Pub Date : 2025-02-20 DOI:10.1111/his.15434
Joseph S Durgin, Nicholas A Zoumberos, Taylor Novice, Douglas R Fullen, Alexandra C Hristov, Lori Lowe, Rajiv M Patel, Paul W Harms, Aleodor A Andea, Scott C Bresler
{"title":"单核苷酸多形性微阵列在bap1失活黑色素细胞肿瘤分类中的作用。","authors":"Joseph S Durgin, Nicholas A Zoumberos, Taylor Novice, Douglas R Fullen, Alexandra C Hristov, Lori Lowe, Rajiv M Patel, Paul W Harms, Aleodor A Andea, Scott C Bresler","doi":"10.1111/his.15434","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>BAP1-inactivated melanocytic tumours (BIMTs) occur sporadically and in association with a familial tumour predisposition syndrome involving germline mutations in the BRCA1-associated protein-1 (BAP1) gene. Here we report the clinical features, histopathologic findings, and chromosomal copy number data of 19 BAP1-inactivated melanocytomas (BIMs) and compare their features to those of five BAP1-inactivated melanomas.</p><p><strong>Methods: </strong>We retrospectively searched the Department of Pathology archives and EMERSE (Electronic Medical Record Search Engine) for BIMTs that had undergone single-nucleotide polymorphism (SNP) microarray testing. Clinical history/follow-up data, detailed histopathologic features, and SNP microarray results were recorded.</p><p><strong>Results: </strong>Overall, four patients (4/13) with BIMs and available clinical history had features suspicious for a germline BAP1 aberration. In BIMs (19 cases), the BAP1-inactivated component showed variable cytologic features, including epithelioid (predominant), rhabdoid, plasmacytoid, and nevoid morphologies. Sentinel lymph node biopsy was negative in all (6/6) patients in which this procedure was performed. No patient diagnosed with a BIM with available clinical follow-up (18/19; mean 38 months) experienced an adverse event. While the histologic appearances of the five melanomas varied, one case resembled a BIM. The median mitotic count was 1/mm<sup>2</sup> (range 0-6 mm<sup>2</sup>) in BIMs compared to 3/mm<sup>2</sup> (range 1-4/mm<sup>2</sup>) in melanomas (P = 0.04). The median number of copy number alterations (CNAs) was two (range 0-6) in indolent cases versus seven (range 6-10) in melanomas (P = 0.0005). The most common molecular aberration after loss of 3p21 was heterozygous loss of the CDKN2A locus, which unlike homozygous loss has not been associated with melanoma.</p><p><strong>Conclusion: </strong>While most BIMs appear to have a favourable prognosis, even those with multiple CNAs, they deserve careful integration of all clinical and pathologic findings. Although not fully diagnostic, a mitotic count of ≥3/mm<sup>2</sup> and ≥6 CNAs in the appropriate context is supportive of a diagnosis of BAP1-inactivated melanoma.</p>","PeriodicalId":13219,"journal":{"name":"Histopathology","volume":" ","pages":""},"PeriodicalIF":3.9000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Role of single-nucleotide pleomorphism microarray in the classification of BAP1-inactivated melanocytic tumours.\",\"authors\":\"Joseph S Durgin, Nicholas A Zoumberos, Taylor Novice, Douglas R Fullen, Alexandra C Hristov, Lori Lowe, Rajiv M Patel, Paul W Harms, Aleodor A Andea, Scott C Bresler\",\"doi\":\"10.1111/his.15434\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>BAP1-inactivated melanocytic tumours (BIMTs) occur sporadically and in association with a familial tumour predisposition syndrome involving germline mutations in the BRCA1-associated protein-1 (BAP1) gene. Here we report the clinical features, histopathologic findings, and chromosomal copy number data of 19 BAP1-inactivated melanocytomas (BIMs) and compare their features to those of five BAP1-inactivated melanomas.</p><p><strong>Methods: </strong>We retrospectively searched the Department of Pathology archives and EMERSE (Electronic Medical Record Search Engine) for BIMTs that had undergone single-nucleotide polymorphism (SNP) microarray testing. Clinical history/follow-up data, detailed histopathologic features, and SNP microarray results were recorded.</p><p><strong>Results: </strong>Overall, four patients (4/13) with BIMs and available clinical history had features suspicious for a germline BAP1 aberration. In BIMs (19 cases), the BAP1-inactivated component showed variable cytologic features, including epithelioid (predominant), rhabdoid, plasmacytoid, and nevoid morphologies. Sentinel lymph node biopsy was negative in all (6/6) patients in which this procedure was performed. No patient diagnosed with a BIM with available clinical follow-up (18/19; mean 38 months) experienced an adverse event. While the histologic appearances of the five melanomas varied, one case resembled a BIM. The median mitotic count was 1/mm<sup>2</sup> (range 0-6 mm<sup>2</sup>) in BIMs compared to 3/mm<sup>2</sup> (range 1-4/mm<sup>2</sup>) in melanomas (P = 0.04). The median number of copy number alterations (CNAs) was two (range 0-6) in indolent cases versus seven (range 6-10) in melanomas (P = 0.0005). The most common molecular aberration after loss of 3p21 was heterozygous loss of the CDKN2A locus, which unlike homozygous loss has not been associated with melanoma.</p><p><strong>Conclusion: </strong>While most BIMs appear to have a favourable prognosis, even those with multiple CNAs, they deserve careful integration of all clinical and pathologic findings. Although not fully diagnostic, a mitotic count of ≥3/mm<sup>2</sup> and ≥6 CNAs in the appropriate context is supportive of a diagnosis of BAP1-inactivated melanoma.</p>\",\"PeriodicalId\":13219,\"journal\":{\"name\":\"Histopathology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-02-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Histopathology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/his.15434\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CELL BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Histopathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/his.15434","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的:BAP1失活的黑色素细胞肿瘤(BIMTs)是一种偶发的疾病,与家族性肿瘤易感性综合征有关,涉及brca1相关蛋白-1 (BAP1)基因的种系突变。本文报告了19例bbap1失活黑色素细胞瘤(BIMs)的临床特征、组织病理学发现和染色体拷贝数数据,并将其与5例bbap1失活黑色素细胞瘤的特征进行了比较。方法:我们回顾性地检索了病理科档案和emse(电子病历搜索引擎)中进行了单核苷酸多态性(SNP)微阵列检测的bimt。记录临床病史/随访数据、详细的组织病理学特征和SNP微阵列结果。结果:总体而言,4例(4/13)有bim和现有临床病史的患者有疑似种系BAP1畸变的特征。在19例BIMs中,bap1灭活成分表现出不同的细胞学特征,包括上皮样(主要)、横纹肌样、浆细胞样和网状形态。所有(6/6)行此手术的患者前哨淋巴结活检均为阴性。没有诊断出BIM的患者有可用的临床随访(18/19;平均38个月)发生一次不良事件。虽然5例黑色素瘤的组织学表现各不相同,但一例类似于BIM。BIMs的中位有丝分裂计数为1/mm2(范围0-6 mm2),而黑色素瘤的中位有丝分裂计数为3/mm2(范围1-4/mm2) (P = 0.04)。惰性病例中拷贝数改变(CNAs)的中位数为2(范围0-6),而黑色素瘤患者中位数为7(范围6-10)(P = 0.0005)。3p21缺失后最常见的分子畸变是CDKN2A位点的杂合缺失,这与纯合缺失不同,与黑色素瘤无关。结论:虽然大多数BIMs预后良好,即使是那些有多个CNAs的患者,但他们应该仔细整合所有临床和病理结果。虽然不能完全诊断,但在适当情况下,有丝分裂计数≥3/mm2和≥6个CNAs支持bap1失活黑色素瘤的诊断。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Role of single-nucleotide pleomorphism microarray in the classification of BAP1-inactivated melanocytic tumours.

Aims: BAP1-inactivated melanocytic tumours (BIMTs) occur sporadically and in association with a familial tumour predisposition syndrome involving germline mutations in the BRCA1-associated protein-1 (BAP1) gene. Here we report the clinical features, histopathologic findings, and chromosomal copy number data of 19 BAP1-inactivated melanocytomas (BIMs) and compare their features to those of five BAP1-inactivated melanomas.

Methods: We retrospectively searched the Department of Pathology archives and EMERSE (Electronic Medical Record Search Engine) for BIMTs that had undergone single-nucleotide polymorphism (SNP) microarray testing. Clinical history/follow-up data, detailed histopathologic features, and SNP microarray results were recorded.

Results: Overall, four patients (4/13) with BIMs and available clinical history had features suspicious for a germline BAP1 aberration. In BIMs (19 cases), the BAP1-inactivated component showed variable cytologic features, including epithelioid (predominant), rhabdoid, plasmacytoid, and nevoid morphologies. Sentinel lymph node biopsy was negative in all (6/6) patients in which this procedure was performed. No patient diagnosed with a BIM with available clinical follow-up (18/19; mean 38 months) experienced an adverse event. While the histologic appearances of the five melanomas varied, one case resembled a BIM. The median mitotic count was 1/mm2 (range 0-6 mm2) in BIMs compared to 3/mm2 (range 1-4/mm2) in melanomas (P = 0.04). The median number of copy number alterations (CNAs) was two (range 0-6) in indolent cases versus seven (range 6-10) in melanomas (P = 0.0005). The most common molecular aberration after loss of 3p21 was heterozygous loss of the CDKN2A locus, which unlike homozygous loss has not been associated with melanoma.

Conclusion: While most BIMs appear to have a favourable prognosis, even those with multiple CNAs, they deserve careful integration of all clinical and pathologic findings. Although not fully diagnostic, a mitotic count of ≥3/mm2 and ≥6 CNAs in the appropriate context is supportive of a diagnosis of BAP1-inactivated melanoma.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Histopathology
Histopathology 医学-病理学
CiteScore
10.20
自引率
4.70%
发文量
239
审稿时长
1 months
期刊介绍: Histopathology is an international journal intended to be of practical value to surgical and diagnostic histopathologists, and to investigators of human disease who employ histopathological methods. Our primary purpose is to publish advances in pathology, in particular those applicable to clinical practice and contributing to the better understanding of human disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信